USA flag logo/image

An Official Website of the United States Government

Bacteriophages for reducing Vibrio tubiashii associated mortality of shellfish

Award Information

Agency:
Department of Agriculture
Branch:
N/A
Award ID:
Program Year/Program:
2013 / SBIR
Agency Tracking Number:
2013-00319
Solicitation Year:
2013
Solicitation Topic Code:
8.7
Solicitation Number:
USDA-NIFA-SBIR-003848
Small Business Information
INTRALYTIX INC
351 W CAMDEN ST STE 100 Baltimore, MD 21201-8603
View profile »
Woman-Owned: No
Minority-Owned: No
HUBZone-Owned: No
 
Phase 1
Fiscal Year: 2013
Title: Bacteriophages for reducing Vibrio tubiashii associated mortality of shellfish
Agency: USDA
Contract: 2013-00319
Award Amount: $99,991.00
 

Abstract:

This project aims to develop a phage-based product (VTP-100) that will contain a mixture of lytic phages effective against a variety of hatchery strains of Vibrio tubiashii. V. tubiashii is a major cause of larval shellfish mortality, which results in increased costs to the aquaculture industry and consumer. Therefore, if our V. tubiashii phage preparation is successfully commercialized, its use could have a very significant impact on reducing larval mortality in hatcheries and, potentially, on reducing the cost of producing and buying oysters. On a more general level, if the results of the studies proposed in this application support our idea that lytic phages may be effective in managing V. tubiashii-associated mortality of oyster larvae, the same platform technology could be used to develop similar phage-based products against other bacterial pathogens of concern to the aquaculture industry. The studies proposed in the present Phase I SBIR application are designed to conduct research required to obtain data critical for our subsequent development and commercialization of VTP-100. Phase I SBIR funding will be critical for conducting research with our V. tubiashii bacteriophages, which will provide a foundation for our subsequent Phase II SBIR R & D efforts and for obtaining regulatory approvals and aiding the product's commercialization.

Principal Investigator:

Alexander Sulakvelidze
Chief Scientist
410-625-2533
asulakvelidze@intralytix.com

Business Contact:

John Woloszyn
President and CEO
410-625-3813
jwoloszyn@intralytix.com
Small Business Information at Submission:

INTRALYTIX INC
351 W CAMDEN ST STE 100 Baltimore, MD 21201-8603

EIN/Tax ID: 522112466
DUNS: N/A
Number of Employees:
Woman-Owned: No
Minority-Owned: No
HUBZone-Owned: No